Dendroamide compounds and their use in chemosensitizing multidrug resistant cells
US5869650A · kind A · utility
0Cited by
0References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 21, 1996 |
| Grant date | Feb 9, 1999 |
| Priority date | — |
| Expiry date | Jun 21, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/22
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Dendroamide derivatives are disclosed which are useful in cancer therapy, especially in treating multidrug resistant cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.